4D Molecular Therapeutics Inc

NASDAQ:FDMT 4:00:00 PM EDT

16.85

-0.83 (-4.70%)

4:22:38 PM EDT: $17.19 +0.34 (+2.02%)

Products

4D Molecular Therapeutics Announces FDA Clearance Of Ind Application For 4D-150 Genetic Medicine For The Treatment Of Diabetic Macular Edema

Published: 02/02/2023 22:22 GMT

4D Molecular Therapeutics Inc (FDMT) - 4d Molecular Therapeutics Announces FDA Clearance of Ind Application for 4d-150 Genetic Medicine for the Treatment of Diabetic Macular Edema.
4d Molecular Therapeutics Inc - Randomized Phase 2 Portion of Phase 1/2 Prism Clinical Trial With 4d-150 for Wet Amd is Currently Enrolling.